超越肺部:肺动脉高压的全身表现
本文综述肺动脉高压(PAH)的全身表现,指出患者存在肱动脉血流介导的舒张功能受损、脑血流异常、骨骼肌病和固有肾脏疾病等系统性血管功能障碍。部分异常源于右心功能不全,但近期数据支持其与PAH发病机制的遗传和分子事件存在机制联系。作者提出代谢异常、遗传损伤和系统性血管功能障碍共同参与PAH全身表现的范式,并鼓励临床医生在管理中考虑肺外表现。
要点
- PAH患者存在系统性血管功能障碍,表现为肱动脉血流介导的舒张功能受损、脑血流异常、骨骼肌病和固有肾脏疾病。
- 部分全身异常源于右心功能不全,但近期数据支持其与PAH发病机制的遗传和分子事件存在机制联系。
- 作者提出代谢异常、遗传损伤和系统性血管功能障碍共同参与PAH全身表现的范式,建议临床管理关注肺外表现。
核心结论
- PAH不仅累及肺循环,还表现出系统性血管功能障碍等全身表现,其机制与PAH发病的遗传和分子事件相关。
研究设计与样本
- 本文为综述,检索范围未在摘要中具体报告。
主要发现
- PAH患者存在肱动脉血流介导的舒张功能受损、脑血流异常、骨骼肌病和固有肾脏疾病等系统性异常。
- 部分全身异常部分源于右心室功能不全,但近期数据支持其与PAH发病机制的遗传和分子事件存在机制联系。
- 近期研究描述了全身血管的形态学改变,并探讨支气管肺吻合在丛状动脉病发生中的可能作用。
临床怎么用
- 临床医生在管理PAH患者时应考虑肺外表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary arterial hypertension (PAH) is a disease characterized by progressive loss and remodeling of the pulmonary arteries, resulting in right heart failure and death. Until recently, PAH was seen as a disease restricted to the pulmonary circulation. However, there is growing evidence that patients with PAH also exhibit systemic vascular dysfunction, as evidenced by impaired brachial artery flow-mediated dilation, abnormal cerebral blood flow, skeletal myopathy, and intrinsic kidney disease. Although some of these anomalies are partially due to right ventricular insufficiency, recent data support a mechanistic link to the genetic and molecular events behind PAH pathogenesis. This review serves as an introduction to the major systemic findings in PAH and the evidence that supports a common mechanistic link with PAH pathophysiology. In addition, it discusses recent studies describing morphological changes in systemic vessels and the possible role of bronchopulmonary anastomoses in the development of plexogenic arteriopathy. On the basis of available evidence, we propose a paradigm in which metabolic abnormalities, genetic injury, and systemic vascular dysfunction contribute to systemic manifestations in PAH. This concept not only opens exciting research possibilities but also encourages clinicians to consider extrapulmonary manifestations in their management of patients with PAH.
引用
- Nickel NP, Yuan K, Dorfmuller P, et al. Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020. PMID: 31513751. doi:10.1164/rccm.201903-0656CI
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。